{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:04:12Z","timestamp":1778313852522,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,23]]},"DOI":"10.7759\/cureus.74319","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T20:53:48Z","timestamp":1732395228000},"source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the Role of Maximal Expiratory Flow at 25% (MEF-25) in Detecting and Managing Patients With Small Airway Disease in the United Arab Emirates"],"prefix":"10.7759","author":[{"given":"Aadil Ashraf Ahmed","family":"Shaikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Ann","family":"Boniface","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nida","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Ammar Husain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon Gerard","family":"D Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Arshad","family":"Husain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3402\/ecrj.v1.25898","article-title":"Techniques of assessing small airways dysfunction","volume":"1","author":"McNulty W","year":"2014","unstructured":"McNulty W, Usmani OS. Techniques of assessing small airways dysfunction. Eur Clin Respir J. 2014, 1:10.3402\/ecrj.v1.25898","journal-title":"Eur Clin Respir J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21238907","article-title":"The airway epithelium\u2014a central player in asthma pathogenesis","volume":"21","author":"Calv\u00e9n J","year":"2020","unstructured":"Calv\u00e9n J, Ax E, R\u00e5dinger M. The airway epithelium\u2014a central player in asthma pathogenesis. Int J Mol Sci. 2020, 21:10.3390\/ijms21238907","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47935","article-title":"Oscillometry in lung function assessment: a comprehensive review of current insights and challenges","volume":"15","author":"Sarkar S","year":"2023","unstructured":"Sarkar S, Jadhav U, Ghewade B, Sarkar S, Wagh P. Oscillometry in lung function assessment: a comprehensive review of current insights and challenges. Cureus. 2023, 15:e47935. 10.7759\/cureus.47935","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.2001.1148","article-title":"History and future perspectives of treating asthma as a systemic and small airways disease","volume":"95","author":"Bjermer L","year":"2001","unstructured":"Bjermer L. History and future perspectives of treating asthma as a systemic and small airways disease. Respir Med. 2001, 95:703-719. 10.1053\/rmed.2001.1148","journal-title":"Respir Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2000.111582","article-title":"Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma","volume":"106","author":"Vanden Burgt JA","year":"2000","unstructured":"Vanden Burgt JA, Busse WW, Martin RJ, Szefler SJ, Donnell D. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol. 2000, 106:1209-1226. 10.1067\/mai.2000.111582","journal-title":"J Allergy Clin Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2023.102272","article-title":"Improvement of asthma control in adult patients using extrafine inhaled beclomethasone\/formoterol fixed combination as maintenance therapy as well as maintenance and reliever therapy - CONTROL study","volume":"84","author":"D\u0119bowski T","year":"2024","unstructured":"D\u0119bowski T, Marko M, Rogala B, Majak P, Pawliczak R. Improvement of asthma control in adult patients using extrafine inhaled beclomethasone\/formoterol fixed combination as maintenance therapy as well as maintenance and reliever therapy - CONTROL study. Pulm Pharmacol Ther. 2024, 84:102272. 10.1016\/j.pupt.2023.102272","journal-title":"Pulm Pharmacol Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2021.0046","article-title":"Lung deposition of inhaled extrafine beclomethasone dipropionate\/formoterol fumarate\/glycopyrronium bromide in healthy volunteers and asthma: the STORM study","volume":"35","author":"Usmani OS","year":"2022","unstructured":"Usmani OS, Baldi S, Warren S, et al.. Lung deposition of inhaled extrafine beclomethasone dipropionate\/formoterol fumarate\/glycopyrronium bromide in healthy volunteers and asthma: the STORM study. J Aerosol Med Pulm Drug Deliv. 2022, 35:179-185. 10.1089\/jamp.2021.0046","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2009.0772","article-title":"Lung deposition of BDP\/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients","volume":"23","author":"De Backer W","year":"2010","unstructured":"De Backer W, Devolder A, Poli G, et al.. Lung deposition of BDP\/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. J Aerosol Med Pulm Drug Deliv. 2010, 23:137-148. 10.1089\/jamp.2009.0772","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200410-1414OC","article-title":"Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size","volume":"172","author":"Usmani OS","year":"2005","unstructured":"Usmani OS, Biddiscombe MF, Barnes PJ. Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size. Am J Respir Crit Care Med. 2005, 172:1497-1504. 10.1164\/rccm.200410-1414OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00065-2018","article-title":"Spacer devices for inhaled therapy: why use them, and how?","volume":"4","author":"Vincken W","year":"2018","unstructured":"Vincken W, Levy ML, Scullion J, Usmani OS, Dekhuijzen PN, Corrigan CJ. Spacer devices for inhaled therapy: why use them, and how?. ERJ Open Res. 2018, 4:10.1183\/23120541.00065-2018","journal-title":"ERJ Open Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino R","year":"2005","unstructured":"Pellegrino R, Viegi G, Brusasco V, et al.. Interpretative strategies for lung function tests. Eur Respir J. 2005, 26:948-968. 10.1183\/09031936.05.00035205","journal-title":"Eur Respir J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.10.040","article-title":"Clinical characterization and predictors of IOS-defined small airway dysfunction in asthma","volume":"8","author":"Cottini M","year":"2020","unstructured":"Cottini M, Licini A, Lombardi C, Berti A. Clinical characterization and predictors of IOS-defined small airway dysfunction in asthma. J Allergy Clin Immunol Pract. 2020, 8:997.e2-1004.e2. 10.1016\/j.jaip.2019.10.040","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10822","article-title":"Evaluation of small airway function and its application in patients with chronic obstructive pulmonary disease (Review)","volume":"22","author":"Li Y","year":"2021","unstructured":"Li Y, Li XY, Yuan LR, Wang HL, Pang M. Evaluation of small airway function and its application in patients with chronic obstructive pulmonary disease (Review). Exp Ther Med. 2021, 22:1386. 10.3892\/etm.2021.10822","journal-title":"Exp Ther Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2009.02242.x","article-title":"The small airways and distal lung compartment in asthma and COPD: a time for reappraisal","volume":"65","author":"Contoli M","year":"2010","unstructured":"Contoli M, Bousquet J, Fabbri LM, et al.. The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy. 2010, 65:141-151. 10.1111\/j.1398-9995.2009.02242.x","journal-title":"Allergy"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement","volume":"200","author":"Graham BL","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR, et al.. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019, 200:e70-e88. 10.1164\/rccm.201908-1590ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.05.016","article-title":"Forced expiratory flow between 25% and 75% of vital capacity and FEV1\/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values","volume":"126","author":"Simon MR","year":"2010","unstructured":"Simon MR, Chinchilli VM, Phillips BR, et al.. Forced expiratory flow between 25% and 75% of vital capacity and FEV1\/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values. J Allergy Clin Immunol. 2010, 126:527-534. 10.1016\/j.jaci.2010.05.016","journal-title":"J Allergy Clin Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/136.1.69","article-title":"Longitudinal study of pulmonary function development in childhood, adolescence, and early adulthood. Development of pulmonary function","volume":"136","author":"Lebowitz MD","year":"1987","unstructured":"Lebowitz MD, Holberg CJ, Knudson RJ, Burrows B. Longitudinal study of pulmonary function development in childhood, adolescence, and early adulthood. Development of pulmonary function. Am Rev Respir Dis. 1987, 136:69-75. 10.1164\/ajrccm\/136.1.69","journal-title":"Am Rev Respir Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3109\/02770909709071199","article-title":"Residual abnormalities of pulmonary function in asymptomatic young adult asthmatics with childhood-onset asthma","volume":"34","author":"Chiang CH","year":"1997","unstructured":"Chiang CH, Hsu K. Residual abnormalities of pulmonary function in asymptomatic young adult asthmatics with childhood-onset asthma. J Asthma. 1997, 34:15-21. 10.3109\/02770909709071199","journal-title":"J Asthma"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12506","article-title":"Mechanisms of airway hyper-responsiveness in asthma: the past, present and yet to come","volume":"45","author":"Chapman DG","year":"2015","unstructured":"Chapman DG, Irvin CG. Mechanisms of airway hyper-responsiveness in asthma: the past, present and yet to come. Clin Exp Allergy. 2015, 45:706-719. 10.1111\/cea.12506","journal-title":"Clin Exp Allergy"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S295345","article-title":"Small-airway function variables in spirometry, fractional exhaled nitric oxide, and circulating eosinophils predicted airway hyperresponsiveness in patients with mild asthma","volume":"14","author":"Bao W","year":"2021","unstructured":"Bao W, Zhang X, Yin J, et al.. Small-airway function variables in spirometry, fractional exhaled nitric oxide, and circulating eosinophils predicted airway hyperresponsiveness in patients with mild asthma. J Asthma Allergy. 2021, 14:415-426. 10.2147\/JAA.S295345","journal-title":"J Asthma Allergy"},{"key":"ref21","article-title":"Wheezing and Asthma","author":"Gong H","year":"1990","unstructured":"Gong H. Wheezing and Asthma. Clinical Methods: The History, Physical, and Laboratory Examinations. Walker HK, Hall WD, Hurst JW (ed): Butterworths, Boston; 1990. 3rd:37."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00558-2022","article-title":"Development of a tool to detect small airways dysfunction in asthma clinical practice","volume":"61","author":"Kocks J","year":"2023","unstructured":"Kocks J, van der Molen T, Voorham J, et al.. Development of a tool to detect small airways dysfunction in asthma clinical practice. Eur Respir J. 2023, 61:10.1183\/13993003.00558-2022","journal-title":"Eur Respir J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.09.002","article-title":"Lung function and asthma control with beclomethasone and formoterol in a single inhaler","volume":"103","author":"Huchon G","year":"2009","unstructured":"Huchon G, Magnussen H, Chuchalin A, Dymek L, Gonod FB, Bousquet J. Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med. 2009, 103:41-49. 10.1016\/j.rmed.2008.09.002","journal-title":"Respir Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01493.x","article-title":"Beclomethasone\/formoterol vs fluticasone\/salmeterol inhaled combination in moderate to severe asthma","volume":"62","author":"Papi A","year":"2007","unstructured":"Papi A, Paggiaro P, Nicolini G, Vignola AM, Fabbri LM. Beclomethasone\/formoterol vs fluticasone\/salmeterol inhaled combination in moderate to severe asthma. Allergy. 2007, 62:1182-1188. 10.1111\/j.1398-9995.2007.01493.x","journal-title":"Allergy"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(13)70012-2","article-title":"Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial","volume":"1","author":"Papi A","year":"2013","unstructured":"Papi A, Corradi M, Pigeon-Francisco C, et al.. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial. Lancet Respir Med. 2013, 1:23-31. 10.1016\/S2213-2600(13)70012-2","journal-title":"Lancet Respir Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2011.03820.x","article-title":"Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study","volume":"41","author":"Barnes N","year":"2011","unstructured":"Barnes N, Price D, Colice G, et al.. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study. Clin Exp Allergy. 2011, 41:1521-1532. 10.1111\/j.1365-2222.2011.03820.x","journal-title":"Clin Exp Allergy"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/all.12062","article-title":"Treatment of the bronchial tree from beginning to end: targeting small airway inflammation in asthma","volume":"68","author":"van den Berge M","year":"2013","unstructured":"van den Berge M, ten Hacken NH, van der Wiel E, Postma DS. Treatment of the bronchial tree from beginning to end: targeting small airway inflammation in asthma. Allergy. 2013, 68:16-26. 10.1111\/all.12062","journal-title":"Allergy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/316226-evaluating-the-role-of-maximal-expiratory-flow-at-25-mef-25-in-detecting-and-managing-patients-with-small-airway-disease-in-the-united-arab-emirates","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T20:53:50Z","timestamp":1732395230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/316226-evaluating-the-role-of-maximal-expiratory-flow-at-25-mef-25-in-detecting-and-managing-patients-with-small-airway-disease-in-the-united-arab-emirates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.74319","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,23]]}}}